Pamela Parker
Evaluating the Role of Ultrasound in Prostate Cancer trial – phase 1: Early experience of micro-ultrasound in the United Kingdom
Parker, Pamela; Twiddy, Maureen; Rigby, Alan; Whybrow, Paul; Simms, Matthew
Authors
Dr Maureen Twiddy M.Twiddy@hull.ac.uk
Reader in Mixed Methods Research
Alan Rigby
Paul Whybrow
Matthew Simms
Abstract
Purpose: The purpose of this study was to evaluate if the use of micro-ultrasound can detect clinically significant prostate pathology when compared to histology obtained during a transperineal prostate biopsy. Methods: Patients suspected of having prostate cancer, who had a pre-biopsy magnetic resonance imaging and could tolerate a transrectal examination, were prospectively recruited. All patients had a micro-ultrasound scan prior to their biopsy. The findings of magnetic resonance imaging, micro-ultrasound and histology were risk stratified in accordance with local pathways. Comparison of assigned risk scores was made using histology as the reference standard. Results: Data from 101 patients were evaluated. Histology showed that clinically significant prostate cancer was detected in 48.5% (n = 49/101) of patients. Moderate inter-rater agreement was found in both magnetic resonance imaging and micro-ultrasound with К of 0.31 in both modalities. High-risk findings were identified in 81% (n = 82/101) patients at magnetic resonance imaging and in 66% (n = 67/101) patients at micro-ultrasound. Sensitivity and specificity of magnetic resonance imaging were found to be 87% and 34.6% and for micro-ultrasound 73.3% and 53.8%, respectively. Conclusion: A limitation of this study was that the biopsy was not performed with micro-ultrasound which may have resulted in unidentified cancers and lowered the apparent accuracy of the technique. However, we conclude that while micro-ultrasound was diagnostic, magnetic resonance imaging demonstrated higher sensitivity in our local population and remains the pre-biopsy imaging modality of choice. However, the higher specificity of micro-ultrasound identified does indicate that it may be of value when magnetic resonance imaging is contraindicated. The role of micro-ultrasound, within an active surveillance pathway for prostate cancer, warrants further investigation.
Citation
Parker, P., Twiddy, M., Rigby, A., Whybrow, P., & Simms, M. (2024). Evaluating the Role of Ultrasound in Prostate Cancer trial – phase 1: Early experience of micro-ultrasound in the United Kingdom. Ultrasound, https://doi.org/10.1177/1742271X231226302
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 28, 2023 |
Online Publication Date | Feb 14, 2024 |
Publication Date | Jan 1, 2024 |
Deposit Date | Jan 2, 2024 |
Publicly Available Date | Feb 16, 2024 |
Journal | Ultrasound |
Print ISSN | 1742-271X |
Publisher | SAGE Publications |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1177/1742271X231226302 |
Keywords | Sonographer; MicroUS; Diagnosis; Prostate biopsy; Active surveillance |
Public URL | https://hull-repository.worktribe.com/output/4499614 |
Files
Accepted manuscript
(951 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
Parker P, Twiddy M, Rigby A, Whybrow P, Simms M. Evaluating the Role of Ultrasound in Prostate Cancer trial – phase 1: Early experience of micro-ultrasound in the United Kingdom. Ultrasound. (Journal Volume Number and Issue Number) pp. xx-xx. Copyright © 2024 by The British Medical Ultrasound Society. DOI: https://doi.org/10.1177/1742271X231226302.
You might also like
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search